Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Denver Health and Hospital Authority
Heart failure is a leading cause of death and hospitalization in the US. Designing practical approaches to improving heart failure care is therefore a national health priority. One retrospective study suggested that patients taking beta-blockers while hospitalized for heart failure had a lower risk of rehospitalization at 6-months. One prospective study suggested that starting beta blockers among hospitalized heart failure patients is safe and improves compliance. However, improved outcomes of this approach have not been prospectively demonstrated.
Comparison: Inpatient initiation of the beta-blocker carvedilol coupled with outpatient follow-up with a nurse manager was compared to usual care by internists and cardiologists.
Age
0–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
primary hospitalization with heart failure and LVEF \< 40%
patient informed consent has been obtained
absence of pulmonary congestion
age \> 18 years
You may not be if
End-stage renal or hepatic disease
Acute myocardial infarction as primary diagnosis during index hospitalization
Life-expectancy \< 6-months
Contraindication to beta blocker use
Current beta-blocker therapy
Planned bypass or valve surgery during index hospitalization
Clareo Health | Effects of Carvedilol on Health Outcomes in Heart Failure
